Showing results (141-150 of 2,465) with videos related to
Sort By:
Pageof 247
British Heart Journal|February 1, 1993
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart diseaseA B Bridges, M McLaren, N A Scott, et al.Scottish Medical Journal|February 1, 1987
Abnormal biochemical and cellular parameters in the blood of patients with Raynauds phenomenonJ J Belch, J Drury, K McLaughlin, et al.Thrombosis and Haemostasis|August 30, 1985
Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind studyJ J Belch, B Shaw, A O'Dowd, et al.British Journal of Clinical Pharmacology|June 1, 1993
Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteersJ J Belch, M McLaren, C S Lau, et al.Prostaglandins|July 1, 1984
The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteersJ J Belch, I Greer, M McLaren, et al.Blood|August 1, 1991
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cellsG S Jensen, M J Mant, A J Belch, et al.Clinical Nephrology|May 1, 1994
Erythropoietin response and route of administrationJ E Taylor, J J Belch, L W Fleming, et al.Transplantation|March 1, 1993
Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patientsJ E Taylor, N Scott, A Hill, et al.European Journal of Clinical Pharmacology|January 1, 1992
Dipyridamole increases human red blood cell deformabilityA R Saniabadi, T C Fisher, C S Lau, et al.Annals of the Rheumatic Diseases|December 1, 1984
Decreased plasma fibrinolysis in patients with rheumatoid arthritisJ J Belch, B McArdle, R Madhok, et al.Pageof 247